Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery

New England Journal of Medicine

Volumn 337, Issue 25, 1997, Pages 1785-1791

  Daoud, Emile G ^a,c   Strickberger, S Adam ^a   Man, K Ching ^a   Goyal, Rajiva ^a   Deeb, G Michael ^a   Bolling, Steven F ^a   Pagani, Francis D ^a   Bitar, Cynthia ^a   Meissner, Marc D ^b   Morady, Fred ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RIVERSIDE METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COST; ELECTIVE SURGERY; FEMALE; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN HEART SURGERY; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; DOUBLE-BLIND METHOD; FEMALE; HOSPITAL COSTS; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; PREVALENCE;

EID: 0031468254     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199712183372501     Document Type: Article

References (43)

1. Fuller JA, Adams GG, Buxton B. Atrial fibrillation after coronary artery bypass grafting: is it a disorder of the elderly? J Thorac Cardiovasc Surg 1989;97:821-5.
2. Michelson EL, Morganroth J, MacVaugh H III. Postoperative arrhythmias after coronary artery and cardiac valvular surgery detected by long-term electrocardiographic monitoring. Am Heart J 1979;97:442-8.
3. Ormerod OJM, McGregor CGA, Stone DL, Wisbey C, Petch MC. Arrhythmias after coronary bypass surgery. Br Heart J 1984;51:618-21.
4. Leitch JW, Thomson D, Baird DK, Harris PJ. The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1990;100:338-42.
5. Lauer MS, Eagle KA, Buckley MJ, DeSanctis RW. Atrial fibrillation following coronary artery bypass surgery. Prog Cardiovasc Dis 1989;31:367-78.
6. Caretta Q, Mercanti CA, De Nardo D, et al. Ventricular conduction defects and atrial fibrillation after coronary artery bypass grafting: multivariate analysis of preoperative, intraoperative and postoperative variables. Eur Heart J 1991;12:1107-11.
7. Crosby LH, Pifalo WB, Woll KR, Burkholder JA. Risk factors for atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 1990;66: 1520-2.
8. Rubin DA, Nieminski KE, Reed GE, Herman MV. Predictors, prevention, and long-term prognosis of atrial fibrillation after coronary artery by-pass graft operations. J Thorac Cardiovasc Surg 1987;94:331-5.
9. Yousif H, Davies G, Oakley CM. Peri-operative supraventricular arrhythmias in coronary bypass surgery. Int J Cardiol 1990;26:313-8.
10. Parikka H, Toivonen L, Pellinen T, Verkkala K, Jarvinen A, Neiminen MS. The influence of intravenous magnesium sulphate on the occurrence of atrial fibrillation after coronary artery by-pass operation. Eur Heart J 1993;14:251-8.
11. White HD, Antman EM, Glynn MA, et al. Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. Circulation 1984;70:479-84.
12. Johnson LW, Dickstein RA, Fruehan CT, et al. Prophylactic digitalization for coronary artery bypass surgery. Circulation 1976;53:819-22.
13. Daudon P, Corcos T, Gandjbakhch I, Levasseur JP, Cabrol A, Cabrol C. Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting. Am J Cardiol 1986;58:933-6.
14. Lamb RK, Prabhakar G, Thorpe JAC, Smith S, Norton R, Dyde JA. The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery. Eur Heart J 1988;9:32-6.
15. Janssen J, Loomans L, Harink J, et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology 1986;37:601-9.
16. Suttorp MJ, Kingma JH, Tjon Joe Gin RM, et al. Efficacy and safety of low-and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations. J Thorac Cardiovasc Surg 1990;100:921-6.
17. Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thorac Cardiovasc Surg 1993;41:34-7.
18. Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation 1996;94:390-7.
19. Brodsky MA, Allen BJ, Walker CJ III, Casey TP, Luckett CR, Henry WL. Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium. Am J Cardiol 1987;60: 572-5.
20. Gold RL, Haffajee CI, Charos G, Sloan K, Baker S, Alpert JS. Amiodarone for refractory atrial fibrillation. Am J Cardiol 1986;57:124-7.
21. Chun S, Sager P, Stevenson W, Nademanee K, Middlekauff H, Singh B. Amiodarone is highly effective in maintaining NSR in refractory atrial fibrillation/flutter. J Am Coll Cardiol 1993;21:203A.
22. Horowitz LN, Spielman SR, Greenspan AM, et al. Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy. J Am Coll Cardiol 1985;6:1402-7.
23. Blevins RD, Kerin NZ, Benaderet D, et al. Amiodarone in the management of refractory atrial fibrillation. Arch Intern Med 1987;147:1401-4.
24. Gosselink ATM, Crijns HJGM, Van Gelder IC, Hillige H, Wiesfeld ACP, Lie KI. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA 1992;267:3289-93.
25. Middlekauff HR, Wiener I, Stevenson WG. Low-dose amiodarone for atrial fibrillation. Am J Cardiol 1993;72:75F-81F.
26. Nicklas JM, McKenna WJ, Stewart RA, et al. Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J 1991;122:1016-21.
27. Levy S, Lauribe P, Dolla E, et al. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 1992; 86:1415-20.
28. Red book update: issue 29. Montvale, N.J.: Medical Economics, 1997: 16.
29. Harris L, McKenna WJ, Rowland E, Holt DW, Story GC, Krikler DM. Side effects of long-term amiodarone therapy. Circulation 1983;67:45-51.
30. Naccarelli GV, Rinkenberger RL, Dougherty AH, Giebel RA. Amiodarone: pharmacology and antiarrhythmic and adverse effects. Pharmacotherapy 1985;5:298-313.
31. Van Mieghem W, Coolen L, Malysse I, Lacquer LM, Deneffe GJ, Demedts MG. Amiodarone and the development of ARDS after lung surgery. Chest 1994;105:1642-5.
32. Kay GN, Epstein AE, Kirklin JK, Diethelm AG, Graybar G, Plumb VJ. Fatal postoperative amiodarone pulmonary toxicity. Am J Cardiol 1988;62: 490-2.
33. Greenspon AJ, Kidwell GA, Hurley W, Mannion J. Amiodarone-related postoperative adult respiratory distress syndrome. Circulation 1991;84: Suppl III:III-407-III-415.
34. Mason JW. Amiodarone. N Engl J Med 1987;316:455-66.
35. Hamer AWF, Arides LB, Johns JA. Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial. J Am Coll Cardiol 1989;14:1768-74.
36. Hondeghem LM. Class III agents: amiodarone, bretylium, and sotalol. In: Zipes DP, Jalife J, eds. Cardiac electrophysiology: from cell to bedside. 2nd ed. Philadelphia: W.B. Saunders, 1995:1330-6.
37. Hohnloser SH, Meinertz T, Dammbacher T, et al. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. Am Heart J 1991;121:89-95.
38. Ivey MF, Ivey TD, Bailey WW, Williams DB, Hessel EA II, Miller DW Jr. Influence of propranolol on supraventricular tachycardia early after coronary artery revascularization: a randomized trial. J Thorac Cardiovasc Surg 1983;85:214-8.
39. Martinussen HJ, Lolk A, Szczepanski C, Alstrup P. Supraventricular tachyarrhythmias after coronary bypass surgery - a double-blind randomized trial of prophylactic low dose propranolol. Thorac Cardiovasc Surg 1988;36:206-7.
40. Shafei H, Nashef SA, Turner MA, Bain WH. Does low-dose propranolol reduce the incidence of supraventricular tachyarrhythmias following myocardial revascularization? A clinical study. Thorac Cardiovasc Surg 1988;36:202-5.
41. Frost L, Molgaard H, Christiansen EH, Hjortholm K, Paulsen PK, Thomsen PE. Atrial fibrillation and flutter after coronary artery bypass surgery: epidemiology, risk factors and preventive trials. Int J Cardiol 1992; 36:253-61.
42. Abel RM, Van Gelder H, Pores IH, Liguori J, Gielchinsky I, Parsonnet V. Continued propranolol administration following coronary bypass surgery: antiarrhythmic effects. Arch Surg 1983;118:727-31.
43. Silverman NA, Wright R, Levitsky S. Efficacy of low-dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Ann Surg 1982;196:194-7.